1 year return (CAGR)
-82.33%
Enlivex Therapeutics Ltd Exchange (NASDAQ, USD)
ENLV
0.20
-0.02 (-8.48%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-47.29%
5 year return (CAGR)
-53.57%
10 year return (CAGR)
-43.83%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
4.08M
Price/Sales
-
Ent value
1.00B
Price/Book
0.00
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
0.00
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.23 |
| Daily high | 0.23 |
| Daily low | 0.20 |
| Daily Volume | 453K |
| All-time high | 391.60 |
| 1y analyst estimate | 80.00 |
| Beta | 1.42 |
| EPS (TTM) | 212.43 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ENLV | S&P500 | |
| Current price drop from All-time high | -99.95% | -1.94% |
| Highest price drop | -99.95% | -56.47% |
| Date of highest drop | 16 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -88.90% | -10.66% |
| Avg time to new high | 279 days | 12 days |
| Max time to new high | 3053 days | 1805 days |
News
